Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$40.40
+2.4%
$41.80
$31.01
$50.21
$20.52B0.623.68 million shs3.22 million shs
Insulet Co. stock logo
PODD
Insulet
$164.42
-1.1%
$173.42
$125.82
$335.91
$11.51B0.98871,903 shs677,655 shs
ResMed Inc. stock logo
RMD
ResMed
$180.35
+0.8%
$186.14
$132.24
$243.52
$26.53B0.671.01 million shs1.12 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$375.46
+0.9%
$377.94
$310.42
$415.73
$27.49B1.04510,152 shs510,492 shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
+2.36%+0.90%-3.67%+5.17%-10.80%
Insulet Co. stock logo
PODD
Insulet
-1.10%-5.47%+0.07%-19.52%-48.51%
ResMed Inc. stock logo
RMD
ResMed
+0.84%-2.56%-6.07%+3.07%-20.92%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
+0.92%-0.88%-4.69%+6.78%+2.62%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baxter International Inc. stock logo
BAX
Baxter International
4.9271 of 5 stars
3.15.02.54.03.21.72.5
Insulet Co. stock logo
PODD
Insulet
4.6983 of 5 stars
3.43.00.04.92.40.83.1
ResMed Inc. stock logo
RMD
ResMed
4.8359 of 5 stars
3.41.04.24.52.61.72.5
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.7838 of 5 stars
2.45.01.73.22.62.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.22
Hold$46.3014.60% Upside
Insulet Co. stock logo
PODD
Insulet
2.80
Moderate Buy$243.2147.92% Upside
ResMed Inc. stock logo
RMD
ResMed
2.70
Moderate Buy$199.2010.45% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.80
Moderate Buy$435.2015.91% Upside

Current Analyst Ratings

Latest WST, PODD, BAX, and RMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2024
Baxter International Inc. stock logo
BAX
Baxter International
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$41.00 ➝ $44.00
4/1/2024
ResMed Inc. stock logo
RMD
ResMed
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$215.00 ➝ $224.00
3/27/2024
ResMed Inc. stock logo
RMD
ResMed
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$215.00
3/5/2024
Baxter International Inc. stock logo
BAX
Baxter International
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$42.00 ➝ $45.00
2/26/2024
Insulet Co. stock logo
PODD
Insulet
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$214.00 ➝ $213.00
2/23/2024
Insulet Co. stock logo
PODD
Insulet
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$250.00 ➝ $230.00
2/23/2024
Insulet Co. stock logo
PODD
Insulet
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$190.00 ➝ $225.00
2/16/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$400.00 ➝ $375.00
2/13/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$440.00 ➝ $470.00
2/12/2024
Baxter International Inc. stock logo
BAX
Baxter International
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$52.00 ➝ $54.00
2/9/2024
Baxter International Inc. stock logo
BAX
Baxter International
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$38.00 ➝ $44.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$14.81B1.39$5.37 per share7.53$16.69 per share2.42
Insulet Co. stock logo
PODD
Insulet
$1.70B6.78$3.75 per share43.81$10.49 per share15.67
ResMed Inc. stock logo
RMD
ResMed
$4.22B6.28$7.88 per share22.90$28.11 per share6.42
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.95B9.32$10.27 per share36.55$39.31 per share9.55

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
$2.66B$5.227.7412.632.1217.77%19.49%4.77%5/2/2024 (Confirmed)
Insulet Co. stock logo
PODD
Insulet
$206.30M$2.9156.5042.492.9912.16%32.19%7.93%5/9/2024 (Confirmed)
ResMed Inc. stock logo
RMD
ResMed
$897.56M$6.0529.8121.782.1919.77%23.86%14.78%4/25/2024 (Confirmed)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$593.40M$7.8847.6541.176.3620.12%21.60%16.26%4/25/2024 (Confirmed)

Latest WST, PODD, BAX, and RMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Insulet Co. stock logo
PODD
Insulet
$0.39N/A-$0.39N/AN/AN/A  
5/2/2024N/A
Baxter International Inc. stock logo
BAX
Baxter International
$0.61N/A-$0.61N/AN/AN/A  
4/25/2024N/A
ResMed Inc. stock logo
RMD
ResMed
$1.93N/A-$1.93N/AN/AN/A  
4/25/2024N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.31N/A-$1.31N/AN/AN/A  
2/22/2024Q4 2023
Insulet Co. stock logo
PODD
Insulet
$0.67$1.40+$0.73$1.36$461.26 million$509.80 million    
2/15/202412/31/2023
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.78$1.83+$0.05$1.83$740.43 million$732.00 million      
2/8/2024Q4 2023
Baxter International Inc. stock logo
BAX
Baxter International
$0.86$0.88+$0.02$1.28$3.81 billion$3.89 billion    
1/24/2024Q2 24
ResMed Inc. stock logo
RMD
ResMed
$1.81$1.88+$0.07$2.34$1.15 billion$1.16 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$1.162.87%+6.70%22.22%N/A
Insulet Co. stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$1.921.06%+5.66%31.74%12 Years
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.800.21%+5.81%10.15%1 Years

Latest WST, PODD, BAX, and RMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/20/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.23%4/23/20244/24/20245/1/2024
2/12/2024
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.292.88%2/29/20243/1/20244/1/2024
1/24/2024
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.481.12%2/7/20242/8/20243/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.31
1.48
1.04
Insulet Co. stock logo
PODD
Insulet
1.86
3.51
2.62
ResMed Inc. stock logo
RMD
ResMed
0.27
3.11
1.89
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.03
2.88
2.24

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Insulet Co. stock logo
PODD
Insulet
N/A
ResMed Inc. stock logo
RMD
ResMed
54.98%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.22%
Insulet Co. stock logo
PODD
Insulet
0.90%
ResMed Inc. stock logo
RMD
ResMed
1.21%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
60,000507.83 million506.71 millionOptionable
Insulet Co. stock logo
PODD
Insulet
3,00070.02 million69.46 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
10,140147.09 million145.31 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60073.21 million72.82 millionOptionable

WST, PODD, BAX, and RMD Headlines

SourceHeadline
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
zacks.com - April 22 at 10:46 AM
West Pharmaceutical Services, Inc. Plans Quarterly Dividend of $0.20 (NYSE:WST)West Pharmaceutical Services, Inc. Plans Quarterly Dividend of $0.20 (NYSE:WST)
americanbankingnews.com - April 22 at 8:28 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by abrdn plcWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by abrdn plc
marketbeat.com - April 22 at 7:20 AM
Ardevora Asset Management LLP Sells 11,511 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Ardevora Asset Management LLP Sells 11,511 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 21 at 9:25 PM
Federated Hermes Inc. Sells 52,190 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Federated Hermes Inc. Sells 52,190 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 20 at 7:17 AM
Ex-Dividend Reminder: Lennar, Lowe’s And West PharmaceuticalEx-Dividend Reminder: Lennar, Lowe’s And West Pharmaceutical
forbes.com - April 19 at 10:24 AM
Ninety One UK Ltd Has $12.09 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)Ninety One UK Ltd Has $12.09 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 19 at 9:14 AM
Strong Buy: West Pharmaceutical Services’ Market Position and Growth Prospects in Drug Packaging IndustryStrong Buy: West Pharmaceutical Services’ Market Position and Growth Prospects in Drug Packaging Industry
markets.businessinsider.com - April 18 at 1:51 PM
Ninety One North America Inc. Acquires 2,368 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Ninety One North America Inc. Acquires 2,368 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 18 at 1:33 PM
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
zacks.com - April 18 at 11:07 AM
West Pharmaceutical Services (WST) to Release Quarterly Earnings on ThursdayWest Pharmaceutical Services (WST) to Release Quarterly Earnings on Thursday
americanbankingnews.com - April 18 at 3:20 AM
Q2 2024 EPS Estimates for West Pharmaceutical Services, Inc. Increased by Zacks Research (NYSE:WST)Q2 2024 EPS Estimates for West Pharmaceutical Services, Inc. Increased by Zacks Research (NYSE:WST)
americanbankingnews.com - April 18 at 2:20 AM
Analysts Offer Predictions for West Pharmaceutical Services, Inc.s Q2 2024 Earnings (NYSE:WST)Analysts Offer Predictions for West Pharmaceutical Services, Inc.'s Q2 2024 Earnings (NYSE:WST)
marketbeat.com - April 17 at 4:48 PM
Heres Why We Think West Pharmaceutical Services, Inc.s (NYSE:WST) CEO Compensation Looks Fair for the time beingHere's Why We Think West Pharmaceutical Services, Inc.'s (NYSE:WST) CEO Compensation Looks Fair for the time being
finance.yahoo.com - April 17 at 9:53 AM
Everence Capital Management Inc. Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)Everence Capital Management Inc. Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 17 at 9:33 AM
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio NowReasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
zacks.com - April 17 at 8:46 AM
Zacks Research Research Analysts Lower Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)Zacks Research Research Analysts Lower Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)
americanbankingnews.com - April 17 at 1:22 AM
Q1 2024 EPS Estimates for West Pharmaceutical Services, Inc. Reduced by Zacks Research (NYSE:WST)Q1 2024 EPS Estimates for West Pharmaceutical Services, Inc. Reduced by Zacks Research (NYSE:WST)
marketbeat.com - April 16 at 7:27 AM
West Pharmaceutical Services to Announce Q1 Results, Hosts Conference CallWest Pharmaceutical Services to Announce Q1 Results, Hosts Conference Call
msn.com - April 15 at 8:01 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by International Assets Investment Management LLCWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by International Assets Investment Management LLC
marketbeat.com - April 15 at 4:44 AM
Allspring Global Investments Holdings LLC Sells 55,358 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Allspring Global Investments Holdings LLC Sells 55,358 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 14 at 5:36 AM
West to Host First-Quarter 2024 Conference CallWest to Host First-Quarter 2024 Conference Call
prnewswire.com - April 11 at 6:00 AM
New York State Teachers Retirement System Sells 3,791 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)New York State Teachers Retirement System Sells 3,791 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 8 at 6:42 AM
Boston Trust Walden Corp Decreases Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Boston Trust Walden Corp Decreases Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 6 at 6:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Baxter International logo

Baxter International

NYSE:BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Insulet logo

Insulet

NASDAQ:PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
ResMed logo

ResMed

NYSE:RMD
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
West Pharmaceutical Services logo

West Pharmaceutical Services

NYSE:WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.